Mr. Daniel Yi reports

MEDMEN REVISES EXECUTIVE COMPENSATION PLANS

The grant of units for Medmen Enterprises Inc.'s co-founders under its long-term incentive plan (LTIP) will now vest upon achievement of certain share price goals.

Co-founder and chief executive officer Adam Bierman, and co-founder and president Andrew Modlin will receive their LTIP units of MM Enterprises USA LLC according to the following schedule. One-third of the total units will vest when the price of Medmen's subordinated voting shares reaches $10 in the open market, another one-third will vest when the share price reaches $15, and the final one-third will vest when the share price reaches $20. The price will be determined as a five-day volume-weighted average price in any exchange where Medmen shares are traded.

This modification to the grants under the LTIP was made to provide greater economic alignment with Medmen's shareholders.

About Medmen Enterprises Inc.

Medmen Enterprises is the pre-eminent cannabis company in the United States with multiple assets and operations in California, Nevada and New York, which combined account for nearly half of North America's addressable legal market. Medmen owns and operates licensed cannabis facilities in cultivation, manufacturing and retail, and is one of the most well-recognized cannabis brands in the world today.